Yuvraj

King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX Tablets

King Pharmaceuticals®, Inc. and Acura Pharmaceuticals, Inc. announced that King has submitted a New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets to the...

Merck KGaA and sanofi-aventis Sign Agreement to Jointly Investigate Novel Combinations Against Cancer

Merck KGaA announced today that it has signed a worldwide research and development agreement with sanofi-aventis U.S. Inc., under which its division Merck Serono...

Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria Vaccine

Development of a vaccine to prevent the malaria parasite from entering the human liver is the goal of a new collaboration announced by global...

Merck Serono and San Raffaele Institute to Collaborate on Research

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced a strategic collaboration with the Institute of Experimental Neurology (INSpe) and the Department of...

Genentech Phase II study shows Pertuzumab and Herceptin Plus Chemotherapy Significantly Improved the Rate of Complete Tumor

Genentech, a member of the Roche Group announced results from the NEOSPHERE trial, a Phase II neoadjuvant study evaluating the effect of a novel...

Addex Awarded EuropaBio’s Most Innovative SME Award

Allosteric modulation company Addex Pharmaceuticals announced that the company has been awarded EuropaBio’s Most Innovative SME Award. This is the first time that the...

Novartis study shows drug Afinitor plus hormonal therapy delays disease progression in advanced metastatic breast cancer patients

A new study shows that the addition of everolimus (Afinitor® tablets) to the hormonal therapy tamoxifen in patients with hormone-receptor positive/human epidermal growth factor...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read